Grifols logo

Grifols

Europe, Catalonia, Spain, Barcelona

Description

Grifols is a global healthcare company.

Investor Profile

Grifols has made 6 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Private Equity (33%)
  • Corporate Round (17%)
  • Undisclosed (17%)
  • Series B (17%)
  • Series Unknown (17%)

Country Focus

  • United States (50%)
  • Belgium (33%)
  • Spain (17%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Medical Device
  • Oncology
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Grifols frequently co-invest with?

LS
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
HV
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 2

What are some of recent deals done by Grifols?

GigaGen

South San Francisco, California, United States

GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.

BiotechnologyGeneticsMedicalTherapeutics
Private EquityJul 7, 2017
Amount Raised: $35,000,000
Singulex

Alameda, California, United States

Singulex develops direct molecular detection technology, cardiovascular monitoring, and related solutions to understand and manage diseases.

BiotechnologyHealth CareLife ScienceMedical
Private EquityJun 1, 2016
Amount Raised: $50,000,000
Alkahest

San Carlos, California, United States

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.

BiotechnologyHealth CareMedical
Corporate RoundMar 4, 2015
Amount Raised: $37,500,000
Celyad

Mont-saint-guibert, Brabant Wallon, Belgium

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

BiotechnologyMedical DeviceOncologyTherapeutics
Series UnknownMay 8, 2013
Amount Raised: $24,982,151
VCN Biosciences

Barcelona, Catalonia, Spain

VCN Biosciences specializes in the research and development of new treatments for tumors.

Biotechnology
UndisclosedJul 9, 2012
Celyad

Mont-saint-guibert, Brabant Wallon, Belgium

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

BiotechnologyMedical DeviceOncologyTherapeutics
Series BJan 19, 2009
Amount Raised: $9,497,954